David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Xerox
XRX
$381M
| $43.1M | 0.04% |
1,776,339
-423,502
| -19% | -$10.1M |
|
502
PUT
Bristol-Myers Squibb
BMY
$137B
| $43M | 0.04% |
681,500
-1,076,000
| -61% | -$66.9M |
|
|
JKS
503
JinkoSolar
JKS
$834M
| $42.9M | 0.04% |
1,029,048
-1,176,814
| -53% | -$66M |
|
504
Ovintiv
OVV
$18.5B
| $42.8M | 0.04% |
1,797,918
+1,695,934
| +1,663% | +$36.3M |
|
505
F5
FFIV
$21.8B
| $42.8M | 0.04% |
205,147
-48,583
| -19% | -$9.57M |
|
506
Sunrun
RUN
$2.21B
| $42.7M | 0.04% |
+705,977
| New | +$49.1M |
|
507
Royal Bank of Canada
RY
$285B
| $42.7M | 0.04% |
462,700
+227,348
| +97% | +$19.8M |
|
508
Fluor
FLR
$7.01B
| $42.5M | 0.04% |
1,841,409
-698,846
| -28% | -$13.6M |
|
509
PUT
Datadog
DDOG
$84.6B
| $42.5M | 0.04% |
509,700
+139,700
| +38% | +$13.5M |
|
510
CALL
Beyond Meat
BYND
$254M
| $42.3M | 0.04% |
10,830
-3,057
| -22% | -$13.5M |
|
511
Perrigo
PRGO
$1.98B
| $42.3M | 0.04% |
1,044,574
+285,384
| +38% | +$12.2M |
|
512
iHeartMedia
IHRT
$432M
| $42.2M | 0.04% |
2,327,516
+2,222,786
| +2,122% | +$33.6M |
|
513
Floor & Decor
FND
$5.78B
| $42.2M | 0.04% |
441,631
+12,391
| +3% | +$1.21M |
|
514
PUT
Charter Communications
CHTR
$17.9B
| $42M | 0.04% |
68,100
-37,900
| -36% | -$23.7M |
|
515
Pacira BioSciences
PCRX
$983M
| $42M | 0.04% |
598,529
-259,427
| -30% | -$18.5M |
|
|
FSR
516
DELISTED
Fisker Inc.
FSR
| $41.8M | 0.04% |
+2,428,107
| New | +$44.4M |
|
517
Community Health Systems
CYH
$424M
| $41.4M | 0.04% |
3,064,769
+346,624
| +13% | +$3.4M |
|
518
SiteOne Landscape Supply
SITE
$4.19B
| $41.4M | 0.04% |
242,539
+55,949
| +30% | +$9.29M |
|
519
PUT
Alphabet (Google) Class C
GOOG
$4.18T
| $41.4M | 0.04% |
400,000
-700,000
| -64% | -$69.4M |
|
520
CALL
TSMC
TSM
$2.17T
| $41.2M | 0.04% |
348,600
+151,500
| +77% | +$18.8M |
|
521
Citizens Financial Group
CFG
$29.4B
| $41.2M | 0.04% |
933,623
+660,348
| +242% | +$27.5M |
|
522
Liberty Media Series C
FWONK
$26.3B
| $41.2M | 0.04% |
983,773
+160,236
| +19% | +$6.77M |
|
523
Guardant Health
GH
$22.9B
| $41M | 0.04% |
268,702
+224,549
| +509% | +$33.9M |
|
524
Vontier
VNT
$4.46B
| $40.9M | 0.04% |
1,352,656
+640,752
| +90% | +$20.9M |
|
525
PUT
HubSpot
HUBS
$12B
| $40.9M | 0.04% |
90,000
+40,000
| +80% | +$17.6M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.